Sotyktu (deucravacitinib) - BMS
Deucravacitinib for refractory lichen planus with post-inflammatory hyperpigmentation in skin of color. (PubMed, JAAD Case Rep) - Sep 20, 2026 - No abstract available 
Journal • Dermatology • Dermatopathology • Lichen Planus
http://www.ncbi.nlm.nih.gov/pubmed/42761263
 
Aditya Dutt; Aliya Mirza; Christopher Logas; Mallory Suhling
 
Sep 20, 2026
 
Prev Next